Viewing Study NCT07231120


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:28 AM
Study NCT ID: NCT07231120
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2025-09-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia
Sponsor: Jiangsu Nutai Biologics Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module